Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Identifying the risk factors for late-stage head and neck cancer.

Literature DB >> 21929305

Identifying the risk factors for late-stage head and neck cancer.

Maria J Worsham.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2011 PMID： 21929305 PMCID： PMC3715314 DOI： 10.1586/era.11.135

Source DB: PubMed Journal: Expert Rev Anticancer Ther ISSN： 1473-7140 Impact factor: 4.512

× No keyword cloud information.

31 in total

1. A causal role for human papillomavirus in head and neck cancer.

Authors: M L Gillison; D R Lowy
Journal: Lancet Date: 2004-05-08 Impact factor: 79.321

2. Race as a social construct in head and neck cancer outcomes.

Authors: Maria J Worsham; George Divine; Rick A Kittles
Journal: Otolaryngol Head Neck Surg Date: 2011-02-04 Impact factor: 3.497

Review 3. DNA methylation and gene silencing in cancer.

Authors: Stephen B Baylin
Journal: Nat Clin Pract Oncol Date: 2005-12

4. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.

Authors: R J Bova; D I Quinn; J S Nankervis; I E Cole; B F Sheridan; M J Jensen; G J Morgan; C J Hughes; R L Sutherland
Journal: Clin Cancer Res Date: 1999-10 Impact factor: 12.531

5. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.

Authors: Paul M Weinberger; Ziwei Yu; Bruce G Haffty; Diane Kowalski; Malini Harigopal; Janet Brandsma; Clarence Sasaki; John Joe; Robert L Camp; David L Rimm; Amanda Psyrri
Journal: J Clin Oncol Date: 2006-01-09 Impact factor: 44.544

6. Influence of time delay and clinical upstaging in the prognosis of head and neck cancer.

Authors: L P Kowalski; A L Carvalho
Journal: Oral Oncol Date: 2001-01 Impact factor: 5.337

7. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors: Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal: J Natl Cancer Inst Date: 2008-02-12 Impact factor: 13.506

8. Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma.

Authors: Kangmei Chen; Raja Sawhney; Mumtaz Khan; Michael S Benninger; Zizheng Hou; Seema Sethi; Josena K Stephen; Maria J Worsham
Journal: Arch Otolaryngol Head Neck Surg Date: 2007-11

9. Health insurance and stage at diagnosis of laryngeal cancer: does insurance type predict stage at diagnosis?

Authors: Amy Y Chen; Nicole M Schrag; Michael Halpern; Andrew Stewart; Elizabeth M Ward
Journal: Arch Otolaryngol Head Neck Surg Date: 2007-08

Review 10. The relationship between "race" and genetics in biomedical research.

Authors: Jada Benn Torres; Rick A Kittles
Journal: Curr Hypertens Rep Date: 2007-06 Impact factor: 4.592

17 in total

1. MicroRNA-Related Genetic Variants Associated with Survival of Head and Neck Squamous Cell Carcinoma.

Authors: Owen M Wilkins; Alexander J Titus; Lucas A Salas; Jiang Gui; Melissa Eliot; Rondi A Butler; Erich M Sturgis; Guojun Li; Karl T Kelsey; Brock C Christensen
Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-06-07 Impact factor: 4.254

2. Models for Predicting Stage in Head and Neck Squamous Cell Carcinoma Using Proteomic and Transcriptomic Data.

Authors: Chanchala D Kaddi; May D Wang
Journal: IEEE J Biomed Health Inform Date: 2015-10-08 Impact factor: 5.772

3. Developing Robust Predictive Models for Head and Neck Cancer across Microarray and RNA-seq Data.

Authors: Chanchala D Kaddi; Wallace H Coulter; May D Wang
Journal: ACM BCB Date: 2015-09

4. Influence of smoking history on the perception of radiation-induced dysgeusia/hypogeusia in patients with head and neck cancer.

Authors: DaMin Park; Shruti Jain; Zachary Quay-De La Vallee; Kathryn Huber; Miriam O'Leary; Arwa M Farag
Journal: Eur Arch Otorhinolaryngol Date: 2020-10-31 Impact factor: 2.503

5. Phase Ib trial of the Toll-like receptor 9 agonist IMO-2055 in combination with 5-fluorouracil, cisplatin, and cetuximab as first-line palliative treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck.

Authors: Jean-Pascal Machiels; Marie-Christine Kaminsky; Ulrich Keller; Tim H Brümmendorf; Thomas Goddemeier; Ulf Forssmann; Jean-Pierre Delord
Journal: Invest New Drugs Date: 2013-02-10 Impact factor: 3.850

6. Genome-scale identification of microRNA-related SNPs associated with risk of head and neck squamous cell carcinoma.

Authors: Owen M Wilkins; Alexander J Titus; Jiang Gui; Melissa Eliot; Rondi A Butler; Erich M Sturgis; Guojun Li; Karl T Kelsey; Brock C Christensen
Journal: Carcinogenesis Date: 2017-10-01 Impact factor: 4.944

7. Identifying epigenetic biomarkers of established prognostic factors and survival in a clinical cohort of individuals with oropharyngeal cancer.

Authors: Ryan Langdon; Rebecca Richmond; Hannah R Elliott; Tom Dudding; Nabila Kazmi; Chris Penfold; Kate Ingarfield; Karen Ho; Andrew Bretherick; Chris Haley; Yanni Zeng; Rosie M Walker; Michael Pawlita; Tim Waterboer; Tom Gaunt; George Davey Smith; Matthew Suderman; Steve Thomas; Andy Ness; Caroline Relton
Journal: Clin Epigenetics Date: 2020-06-29 Impact factor: 6.551